Pacific Biosciences is trading higher at $1.21, up 5.21%, though no clear company-specific catalyst has been identified.
- PacBio’s latest listed releases remain dated August 5.
- A customer success story was posted August 17, but available coverage does not explicitly connect it to the move.
- Broader indexes are lower, so market sentiment does not clearly explain the gain.